Влияние нутритивного статуса на развитие метаболического синдрома - акцент на роль магния

Магний является вторым по распространенности среди внутриклеточных катионов и четвертым - среди катионов организма человека. Он является фактором, влияющим на скорость многих ферментов, которые участвуют в углеводном и энергетическом обмене, обеспечивает сокращение и расслабление мышц, необходим для нормальной неврологической функции, регулирует минерализацию костной ткани, ее равномерный рост, гибкость, прочность и увеличивает репаративный потенциал костей. Его дефицит является распространенным явлением во многих странах и часто недооценивается, так как симптомы гипомагниемии могут быть неспецифичными. К таким симптомам относятся депрессия, усталость, мышечные спазмы и аритмии. Длительный низкий уровень магния связан с повышенным риском хронических неинфекционных заболеваний: остеопороз, саркопения, метаболические нарушения, сердечно-сосудистая патология. Основная причина дефицита магния - недостаток в питании. Существует между низким потреблением магния с пищей и риском развития метаболического синдрома. Дефицит магния распространен среди пациентов с ожирением, причем как у взрослых, так и у детей. Также недостаток этого микроэлемента связан развитием сахарного диабета 2 типа и артериальной гипертензии. Коррекция дефицита магния с помощью питания или применения лекарственных средств, оказывает положительное метаболическое действие.

ожирение, артериальная гипертензия, сахарный диабет 2 типа, сердечно-сосудистые заболевания

1. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2015. Scientific Opinion on Dietary Reference Values for magnesium. Europen Food Safety Authority. the EFSA Journal. 2015;13(7)(4186). doi: 10.2903/j.efsa.2015.4186.

2. Jahnen-Dechent W., Ketteler M. Magnesium basics. Clin Kidney J. 2012;5(Suppl 1): i3-i14. doi: 10.1093/ndtplus/sfr163.

3. Pogozheva A.V. The importance of macro- and microelements of food in optimizing bone mineral density. Consilium Medicum. 2015;17(2):61-65. (in Russ.)@@ Погожева А.В. Значение макро- и микроэлементов пищи в оптимизации минеральной плотности костной ткани. Consilium Medicum. 2015;17(2):61-65.

4. de Baaij J.H., Hoenderop J.G., Bindels R.J. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95(1):1-46. doi: 10.1152/physrev.00012.2014.

5. Von Ehrlich B., Barbagallo M., Classen H.G. et al. Significance of magnesium in insulin resistance, metabolic syndrome, and diabetes - Recommendations of the Association of Magnesium Research e.V. Trace Elem. Electrolytes. 2017;34:124-129. doi:10.5414/TEX01473.

6. Nielsen F.H. Magnesium deficiency and increased inflammation: current perspectives. J Inflamm Res. 2018;11:25-34. doi: 10.2147/JIR.S136742.

7. Mazidi M., Rezaie P., Banach M. Effect of magnesium supplements on serum C-reactive protein: a systematic review and meta-analysis. Arch Med Sci. 2018;14(4):707-716. doi: 10.5114/aoms.2018.75719.

8. Lobionda S., Sittipo P., Kwon H.Y., Lee Y.K. The Role of Gut Microbiota in Intestinal Inflammation with Respect to Diet and Extrinsic Stressors. Microorganisms. 2019;7(8):271. doi: 10.3390/microorganisms7080271.

9. Nielsen F.H. The Problematic Use of Dietary Reference Intakes to Assess Magnesium Status and Clinical Importance. Biol Trace Elem Res. 2019;188(1):52-59. doi: 10.1007/s12011-018-1573-x.

10. Costello R.B., Elin R.J., Rosanoff A. et al. Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come. Adv. Nutr.Int. Rev. J. 2016;7(6):977-993. doi: 10.3945/an.116.012765.

11. Topf J.M, Murray P.T. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord. 2003;4(2):195-206. doi: 10.1023/a:1022950321817.

12. Razzaque M.S. Magnesium: Are We Consuming Enough? Nutrients. 2018;10(12):1863. doi: 10.3390/nu10121863.

13. Al Alawi A.M, Majoni S.W., Falhammar H. Magnesium and Human Health: Perspectives and Research Directions.Int J Endocrinol. 2018;2018:9041694. doi: 10.1155/2018/9041694.

14. van Dronkelaar C., van Velzen A., Abdelrazek M. et al. Minerals and Sarcopenia; The Role of Calcium, Iron, Magnesium, Phosphorus, Potassium, Selenium, Sodium, and Zinc on Muscle Mass, Muscle Strength, and Physical Performance in Older Adults: A Systematic Review. J Am Med Dir Assoc. 2018;19(1):6-11.e3. doi: 10.1016/j.jamda.2017.05.026.

15. Rude R.K., Gruber H.E. Magnesium deficiency and osteoporosis: animal and human observations. J Nutr Biochem. 2004;15(12):710-6. doi: 10.1016/j.jnutbio.2004.08.001.

16. Gromova O.A., Torshin I. Yu., Kobalava Zh.D., Sorokina M.A., Villevalde S.V., Galochkin S.A., Gogoleva I.V., Gracheva O.N., Grishina T.R., Gromov A.N., Egorova E. Yu., Kalacheva A.G., Malyavskaya S.I., Meraï I.A., Semenov V.A. Deficit of Magnesium and States of Hypercoagulation: Intellectual Analysis of Data Obtained From a Sample of Patients Aged 18-50 years From Medical and Preventive Facilities in Russia. Kardiologiia. 2018;58(4):22-35. (In Russ.)@@ Громова О.А., Торшин И.Ю., Кобалава Ж.Д. и соавт. Дефицит магния и гиперкоагуляционные состояния: метрический анализ данных выборки пациентов 18-50 лет лечебно-профилактических учреждений России. Кардиология. 2018;58(4):22-35. doi: 10.18087/cardio.2018.4.10106

17. Gromova O.A., Torshin I. Yu., Kodentsova V.M. Food products: content and absorption of magnesium. Therapy. 2016;5(9):50-60. (in Russ.)@@ Громова О.А., Торшин И.Ю., Коденцова В.М. Пищевые продукты: содержание и усвоение магния. Терапия. 2016;5(9):50-60.

18. Pogozheva A.V., Kodentsova V.M. About recommended consumption and provision of population with potassium and magnesium. RMJ. 2020;3:8-12. (in Russ.)@@ Погожева А.В., Коденцова В.М. О рекомендуемом потреблении и обеспеченности населения калием и магнием. РМЖ. 2020;3:8-12.

19. Kruis W., Phuong Nguyen G. Iron Deficiency, Zinc, Magnesium, Vitamin Deficiencies in Crohn’s Disease: Substitute or Not? Dig Dis. 2016;34(1-2):105-11. doi: 10.1159/000443012.

20. Owczarek D., Rodacki T., Domagała-Rodacka R. et al. Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol. 2016;22(3):895-905. doi: 10.3748/wjg.v22.i3.895.

21. Rondanelli M., Faliva M.A., Gasparri C. et al. Micronutrients Dietary Supplementation Advices for Celiac Patients on Long-Term Gluten-Free Diet with Good Compliance: A Review. Medicina (Kaunas). 2019;55(7):337. doi: 10.3390/medicina55070337.

22. DiNicolantonio J.J., O’Keefe J.H., Wilson W. Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis. Open Heart. 2018;5(1): e000668. doi: 10.1136/openhrt-2017-000668.

23. Bateman S.W. A Quick Reference on Magnesium. Vet Clin North Am Small Anim Pract. 2017;47(2):235-239. doi: 10.1016/j.cvsm.2016.09.002

24. Chrysant S.G. Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias. Expert Rev Cardiovasc Ther. 2019;17(5):345-351. doi: 10.1080/14779072.2019.1615446.

25. Grochowski C., Blicharska E., Baj J. et al. Serum iron, Magnesium, Copper, and Manganese Levels in Alcoholism: A Systematic Review. Molecules. 2019;24(7):1361. doi: 10.3390/molecules24071361.

26. López-González B., Molina-López J., Florea D.I. et al. Association between magnesium-deficient status and anthropometric and clinical-nutritional parameters in posmenopausal women. Nutr Hosp. 2014;29(3):658-64. doi: 10.3305/nh.2014.29.3.7198.

27. Nielsen F.H. Magnesium, inflammation, and obesity in chronic disease. Nutr Rev. 2010;68(6):333-40. doi: 10.1111/j.1753-4887.2010.00293.x.

28. Maier J.A., Castiglioni S., Locatelli L. et al. Magnesium and inflammation: Advances and perspectives. Semin Cell Dev Biol. 2021;115:37-44. doi: 10.1016/j.semcdb.2020.11.002.

29. Lima Mde L., Cruz T., Rodrigues L.E. еt al. Serum and intracellular magnesium deficiency in patients with metabolic syndrome - evidences for its relation to insulin resistance. Diabetes Res Clin Pract. 2009;83(2):257-62. doi: 10.1016/j.diabres.2008.11.019.

30. Ghasemi A., Zahediasl S., Syedmoradi L., Azizi F. Low serum magnesium levels in elderly subjects with metabolic syndrome. Biol Trace Elem Res. 2010;136(1):18-25. doi: 10.1007/s12011-009-8522-7.

31. Wang Y., Wei J., Zeng C. et al. Association between serum magnesium concentration and metabolic syndrome, diabetes, hypertension and hyperuricaemia in knee osteoarthritis: a cross-sectional study in Hunan Province, China. BMJ Open. 2018;8(9): e019159. doi: 10.1136/bmjopen-2017-019159.

32. Song Y., Ridker P.M., Manson J.E. et al. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005;28(6):1438-44. doi: 10.2337/diacare.28.6.1438.

33. McKeown N.M., Jacques P.F., Zhang.X.L. et al. Dietary magnesium intake is related to metabolic syndrome in older Americans. Eur J Nutr. 2008;47(4):210-6. doi: 10.1007/s00394-008-0715-x.

34. Mirmiran P, Shab-Bidar S, Hosseini-Esfahani F. et al. Magnesium intake and prevalence of metabolic syndrome in adults: Tehran Lipid and Glucose Study. Public Health Nutr. 2012;15(4):693-701. doi: 10.1017/S1368980011002941.

35. Choi M.K., Bae Y.J. Relationship between dietary magnesium, manganese, and copper and metabolic syndrome risk in Korean adults: the Korea National Health and Nutrition Examination Survey (2007-2008). Biol Trace Elem Res. 2013;156(1-3):56-66. doi: 10.1007/s12011-013-9852-z.

36. Dibaba D.T., Xun P., Fly.AD. et al. Dietary magnesium intake and risk of metabolic syndrome: a meta-analysis. Diabet Med. 2014;31(11):1301-9. doi: 10.1111/dme.12537.

37. Sarrafzadegan N., Khosravi-Boroujeni H., Lotfizadeh M. et al. Magnesium status and the metabolic syndrome: A systematic review and meta-analysis. Nutrition. 2016;32(4):409-17. doi: 10.1016/j.nut.2015.09.014.

38. Yang N., He L., Li Y. et al. Reduced Insulin Resistance Partly Mediated the Association of High Dietary Magnesium Intake with Less Metabolic Syndrome in a Large Chinese Population. Diabetes Metab Syndr Obes. 2020;13:2541-2550. doi: 10.2147/DMSO.S257884.

39. Fang X., Wang K., Han D. et al. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies. BMC Med. 2016;14(1):210. doi: 10.1186/s12916-016-0742-z.

40. Veronese N., Watutantrige-Fernando S., Luchini C. et al. Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials. Eur J Clin Nutr. 2016;70(12):1354-1359. doi: 10.1038/ejcn.2016.154.

41. Veronese N., Demurtas J., Pesolillo G. et al. Magnesium and health outcomes: an umbrella review of systematic reviews and meta-analyses of observational and intervention studies. Eur J Nutr. 2020 Feb;59(1):263-272. doi: 10.1007/s00394-019-01905-w.

42. Banjanin N, Belojevic G. Relationship of dietary magnesium intake and serum magnesium with hypertension: a review. Magnes Res. 2021;34(4):166-171. doi: 10.1684/mrh.2021.0492

43. Han D., Fang X., Su D. et al. Dietary Calcium Intake and the Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis. Sci Rep. 2019;9(1):19046. doi: 10.1038/s41598-019-55507-x.

44. Moore-Schiltz L., Albert J.M., Singer M.E. et al. Dietary intake of calcium and magnesium and the metabolic syndrome in the National Health and Nutrition Examination (NHANES) 2001-2010 data. Br J Nutr. 2015;114(6):924-35. doi: 10.1017/S0007114515002482.

45. Park S.H., Kim S.K., Bae Y.J. Relationship between serum calcium and magnesium concentrations and metabolic syndrome diagnostic components in middle-aged Korean men. Biol Trace Elem Res. 2012;146(1):35-41. doi: 10.1007/s12011-011-9224-5.

46. Dai Q., Shu X.O., Deng X. et al. Modifying effect of calcium/magnesium intake ratio and mortality: a population-based cohort study. BMJ Open. 2013;3(2): e002111. doi: 10.1136/bmjopen-2012-002111.

47. Morais J.B., Severo J.S., Santos L.R. et al. Role of Magnesium in Oxidative Stress in Individuals with Obesity. Biol Trace Elem Res. 2017;176(1):20-26. doi: 10.1007/s12011-016-0793-1.

48. Jiang S., Ma X., Li M. et al. Association between dietary mineral nutrient intake, body mass index, and waist circumference in U.S. adults using quantile regression analysis NHANES 2007-2014. Peer J. 2020;8: e9127. doi: 10.7717/peerj.9127.

49. Kelly O.J., Gilman J.C., Kim Y., Ilich J.Z. Macronutrient Intake and Distribution in the Etiology, Prevention and Treatment of Osteosarcopenic Obesity. Curr Aging Sci. 2017;10(2):83-105. doi: 10.2174/1874609809666160509122558.

50. Lu L., Chen C., Yang K. et al. Magnesium intake is inversely associated with risk of obesity in a 30-year prospective follow-up study among American young adults. Eur J Nutr. 2020;59(8):3745-3753. doi: 10.1007/s00394-020-02206-3.

51. Devaux S., Adrian M., Laurant P. et al. Dietary magnesium intake alters age-related changes in rat adipose tissue cellularity. Magnes Res. 2016;29(4):175-183. doi: 10.1684/mrh.2016.0406.

52. Castellanos-Gutiérrez A., Sánchez-Pimienta T.G., Carriquiry A. et al. Higher dietary magnesium intake is associated with lower body mass index, waist circumference and serum glucose in Mexican adults. Nutr J. 2018;17(1):114. doi: 10.1186/s12937-018-0422-2.

53. Shamnani G., Rukadikar C., Gupta V. et al. Serum magnesium in relation with obesity. Natl. J. Physiol. Pharm. Pharm. 2018;8(7):1074-1077.doi: 10.5455/njppp.2018.8.0104016022018.

54. Maguire D., Talwar.D, Shiels P.G., McMillan D. The role of thiamine dependent enzymes in obesity and obesity related chronic disease states: A systematic review. Clin Nutr ESPEN. 2018;25:8-17. doi: 10.1016/j.clnesp.2018.02.007.

55. Ansari M.R., Maheshwari N., Shaikh M.A. et al. Correlation of serum magnesium with dyslipidemia in patients on maintenance hemodialysis. Saudi J Kidney Dis Transpl. 2012;23(1):21-5.

56. Deepti R., Nalini G. Anbazhagan Relationship between hypomagnesemia and dyslipidemia in type 2 diabetes mellitus. Asian J. Pharm. Res. Health Care. 2014;6(3):32-36.

57. Hassan S.A.U., Ahmed I., Nasrullah A. et al.Comparison of Serum Magnesium Levels in Overweight and Obese Children and Normal Weight Children. Cureus. 2017;9(8): e1607. doi: 10.7759/cureus.1607.

58. Zaakouk A.M., Hassan M.A., Tolba O.A. Serum magnesium status among obese children and adolescents. Egypt. Pediatr. Assoc. Gaz. 2016;64(1):32-37. doi: 10.1016/j.epag.2015.11.002

59. Dong J.Y., Xun P., He K., Qin L.Q. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care. 2011;34(9):2116-22. doi: 10.2337/dc11-0518.

60. Bertinato J., Wang K.C., Hayward S. Serum Magnesium Concentrations in the Canadian Population and Associations with Diabetes, Glycemic Regulation, and Insulin Resistance. Nutrients. 2017;9(3):296. doi: 10.3390/nu9030296.

61. Esmeralda C.A.C., David P.E., Maldonado I.C. et al. Deranged Fractional Excretion of Magnesium and Serum Magnesium Levels in Relation to Retrograde Glycaemic Regulation in Patients with Type 2 Diabetes Mellitus. Curr Diabetes Rev. 2021;17(1):91-100. doi: 10.2174/1573399816666200714150434.

62. Zhao B, Zeng L, Zhao J. et al. Association of magnesium intake with type 2 diabetes and total stroke: an updated systematic review and meta-analysis. BMJ Open. 2020 Mar;10(3): e032240. doi: 10.1136/bmjopen-2019-032240.

63. Barbagallo M., Dominguez L.J. Magnesium metabolism in type 2 diabetes mellitus, metabolic syndrome and insulin resistance. Arch Biochem Biophys. 2007;458(1):40-7. doi: 10.1016/j.abb.2006.05.007.

64. Günther T. The biochemical function of Mg²+ in insulin secretion, insulin signal transduction and insulin resistance. Magnes Res. 2010;23(1):5-18. doi: 10.1684/mrh.2009.0195.

65. Fang X., Han H., Li M. et al. Dose-Response Relationship between Dietary Magnesium Intake and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Regression Analysis of Prospective Cohort Studies. Nutrients. 2016;8(11):739. doi: 10.3390/nu8110739.

66. Hruby A., Guasch-Ferré M., Bhupathiraju S.N. et al. Magnesium Intake, Quality of Carbohydrates, and Risk of Type 2 Diabetes: Results From Three U.S. Cohorts. Diabetes Care. 2017;40(12):1695-1702. doi: 10.2337/dc17-1143.

67. Kostov K. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling.Int J Mol Sci. 2019;20(6):1351. doi: 10.3390/ijms20061351.

68. Gommers L.M., Hoenderop J.G., Bindels RJ., de Baaij J.H. Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? Diabetes. 2016;65(1):3-13. doi: 10.2337/db15-1028.

69. Huerta M.G., Roemmich J.N., Kington M.L. et al. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care. 2005;28(5):1175-81. doi: 10.2337/diacare.28.5.1175.

70. Ashcroft F.M., Puljung M.C., Vedovato N. Neonatal Diabetes and the KATP Channel: From Mutation to Therapy. Trends Endocrinol Metab. 2017;28(5):377-387. doi: 10.1016/j.tem.2017.02.003.

71. Apell H.J., Hitzler T., Schreiber G. Modulation of the Na, K-ATPase by Magnesium Ions. Biochemistry. 2017;56(7):1005-1016. doi: 10.1021/acs.biochem.6b01243.

72. Han M., Zhang Y., Fang J. et al. Associations between dietary magnesium intake and hypertension, diabetes, and hyperlipidemia. Hypertens Res. 2024;47(2):331-341. doi: 10.1038/s41440-023-01439-z.

73. Tan M.Y., Mo C.Y., Zhao Q. The Association between Magnesium Depletion Score and Hypertension in US Adults: Evidence from the National Health and Nutrition Examination Survey (2007-2018). Biol Trace Elem Res. 2024;202(10):4418-4430. doi: 10.1007/s12011-023-04034-y.

74. Bogdanov A.R., Derbeneva S.A. Study of calcium and magnesium consumption in patients with obesity and arterial hypertension. Nutrition Issues. 2018; 87(5 Supplement):74. (in Russ.) doi: 10.24411/0042-8833-2018-10161.@@ Богданов А.Р., Дербенева С.А. Изучение потребления кальция и магния у больных ожирением и артериальной гипертензией. Вопросы питания. 2018;87(5 приложение):74. doi: 10.24411/0042-8833-2018-10161

75. Guasch-Ferré M., Bulló M., Estruch R. et al. PREDIMED Study Group. Dietary magnesium intake is inversely associated with mortality in adults at high cardiovascular disease risk. J Nutr. 2014;144(1):55-60. DOI: 10.3945/jn.113.183012.

76. Cazzola R., Della Porta M., Manoni M. et al. Going to the roots of reduced magnesium dietary intake: A tradeoff between climate changes and sources. Heliyon. 2020;6(11): e05390. doi: 10.1016/j.heliyon.2020.e05390.

77. ELDerawi W.A., Naser I.A., Taleb M.H., Abutair A.S. The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients. Nutrients. 2018;11(1):44. doi: 10.3390/nu11010044.

78. Navarrete-Cortes A., Ble-Castillo J.L., Guerrero-Romero F. et al. No effect of magnesium supplementation on metabolic control and insulin sensitivity in type 2 diabetic patients with normomagnesemia. Magnes Res. 2014;27(2):48-56. doi: 10.1684/mrh.2014.0361.

79. Razzaghi R., Pidar F., Momen-Heravi M. et al. Magnesium Supplementation and the Effects on Wound Healing and Metabolic Status in Patients with Diabetic Foot Ulcer: a Randomized, Double-Blind, Placebo-Controlled Trial. Biol Trace Elem Res. 2018;181(2):207-215. doi: 10.1007/s12011-017-1056-5.

80. Dibaba D.T., Xun P., Song Y. et al. The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2017;106(3):921-929. doi: 10.3945/ajcn.117.155291.

81. Banjanin N., Belojevic G. Changes of Blood Pressure and Hemodynamic Parameters after Oral Magnesium Supplementation in Patients with Essential Hypertension-An Intervention Study. Nutrients. 2018;10(5):581. doi: 10.3390/nu10050581.

82. Hatzistavri L.S., Sarafidis P.A., Georgianos P.I. et al. Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension. Am J Hypertens. 2009;22(10):1070-5. doi: 10.1038/ajh.2009.126.

83. Mortazavi M., Moeinzadeh F., Saadatnia M. et al. Effect of magnesium supplementation on carotid intima-media thickness and flow-mediated dilatation among hemodialysis patients: a double-blind, randomized, placebo-controlled trial. Eur Neurol. 2013;69(5):309-16. doi: 10.1159/000346427.

84. Joris P.J., Plat J., Bakker S.J., Mensink R.P. Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults. Sci Rep. 2017;7(1):106. doi: 10.1038/s41598-017-00205-9.

85. Rodríguez-Morán M., Simental-Mendía L.E., Gamboa-Gómez C.I., Guerrero-Romero F. Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Adv Chronic Kidney Dis. 2018;25(3):261-266. doi: 10.1053/j.ackd.2018.02.011.

86. Simental-Mendía L.E., Simental-Mendía M., Sahebkar A. et al. Effect of magnesium supplementation on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Pharmacol. 2017;73(5):525-536. doi: 10.1007/s00228-017-2212-8.

87. Cosaro E., Bonafini S., Montagnana M. et al. Effects of magnesium supplements on blood pressure, endothelial function and metabolic parameters in healthy young men with a family history of metabolic syndrome. Nutr Metab Cardiovasc Dis. 2014;24(11):1213-20. doi: 10.1016/j.numecd.2014.05.010.

88. Piuri G, Zocchi M, Della Porta M. et al. Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes. Nutrients. 2021;13(2):320. doi: 10.3390/nu13020320.

89. Pardo M.R., Garicano Vilar E., San Mauro Martín I., Camina Martín M.A. Bioavailability of magnesium food supplements: A systematic review. Nutrition. 2021;89:111294. doi: 10.1016/j.nut.2021.111294.